Core Viewpoint - Japan Union Technology (688531.SH) reported a significant increase in revenue and net profit for the first three quarters of 2025, indicating strong business performance and growth potential [1] Financial Performance - The company achieved a total operating revenue of 737 million yuan, representing a year-on-year growth of 44.01% [1] - The net profit attributable to shareholders reached 125 million yuan, reflecting an 18.83% increase compared to the previous year [1] - Basic earnings per share were reported at 0.75 yuan [1]

Group 1 - Company reported Q3 performance with revenue of approximately 737 million yuan, a year-on-year increase of 44.01% [1] - Net profit attributable to shareholders was about 125 million yuan, reflecting a year-on-year increase of 18.83% [1] - Basic earnings per share reached 0.75 yuan, up 19.05% year-on-year [1] Group 2 - As of the report, the market capitalization of the company is 11.9 billion yuan [2]

Core Viewpoint - The acquisition of 66% stake in SSTI by the company’s wholly-owned subsidiary in Singapore is a strategic move to enhance its position in the high-end semiconductor testing equipment sector, integrating technologies and expanding market reach [1][2]. Group 1: Acquisition Details - The company plans to use its own funds amounting to 4,890 million Singapore dollars (approximately 268.95 million RMB) for the acquisition [1]. - Upon completion of the transaction, the company will hold a 66% stake in SSTI, which will become a controlled subsidiary and included in the company’s consolidated financial statements [1]. Group 2: Target Company Overview - SSTI is a leading supplier of semiconductor testing, diagnostics, and failure analysis equipment, headquartered in Singapore [1]. - The target company possesses over 30 years of experience in the research and development of semiconductor testing and diagnostic equipment, with a strong technological advantage [1]. - SSTI has developed and commercialized several industry-leading technologies, including core products such as Photon Emission Microscopes (PEM), Laser Timing Probes (LTP), Scanning Optical Microscopes (SOM), and Thermal Microscopes (THM) [1]. Group 3: Strategic Implications - This acquisition aligns with the company's strategy of "horizontal expansion and vertical deepening," allowing for the integration of technologies, products, and markets [2]. - The move is expected to create synergies with the company’s existing semiconductor X-ray detection business, enhancing its technical capabilities and business scope in the industrial testing sector [2]. - The acquisition supports the company's vision of becoming a platform enterprise in industrial testing, consistent with its long-term strategic planning [2].

证券代码：688531 证券简称：日联科技 公告编号：2025-065 日联科技集团股份有限公司 关于全资子公司收购境外公司控制权的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 日联科技集团股份有限公司（以下简称"日联科技"或"公司"）全资 子公司RAY TECH SINGAPORE PTE. LTD（中文名：瑞泰（新加坡）私人有限 公司，以下简称"新加坡瑞泰"）拟使用自有资金4,890万元新币（折合约人民 币 26,895 万 元 ， 最 终 交 易 金 额 以 实 际 交 割 时 汇 率 为 准 ） 收 购 SCPL SEMICONDUCTOR TEST & INSPECTION PTE. LTD.（以下简称"SSTI"或 "目标公司"）66%股权。本次交易完成后，公司持有SSTI股权比例为66%， SSTI将成为公司控股孙公司，纳入公司合并报表范围内。 目标公司全体现有股东已获悉本次交易的相关情况，现有股东承诺放弃 优先认购权。 基于 SSTI 所处行业的发展前景及其近年来的经营情况、业务发展 ...

国泰海通证券股份有限公司 关于日联科技集团股份有限公司 使用自有资金支付募投项目部分款项并以募集资金等额置 换的核查意见 三、使用自有资金支付募投项目部分款项并以募集资金等额置换的原因 国泰海通证券股份有限公司(以下简称"国泰海通"或"保荐机构")作为目联 科技集团股份有限公司(以下简称"日联科技"或"公司")首次公开发行股票并在 科创板上市持续督导阶段的保荐机构,根据《中华人民共和国公司法》《证券发 行上市保荐业务管理办法》《上市公司募集资金监管规则》《上海证券交易所科 创板上市公司自律监管指引第1号 -- 规范运作》等有关规定,对日联科技使用 自有资金支付募投项目部分款项并以募集资金等额置换事项进行了核查,具体情 况如下: 一、募集资金的基本情况 经中国证券监督管理委员会于 2023年2月21日出具的《关于同意无锡日联 科技股份有限公司首次公开发行股票注册的批复》（证监许可[2023]366 号）， 公司向社会公开发行人民币普通股(A 股)1,985.1367万股,发行价格 152.38元 /股,募集资金总额为人民币 302,495.13 万元,扣除各项发行费用后的实际募集 资金净额为人民币 273,07 ...

SCPL Semiconductor Test &Inspection Pte. Ltd. 主要会计政策与中国会计准则差异情况表 鉴证报告 | 录 | | --- | | 目 | 二、注册会计师的责任 我们的责任是在执行鉴证工作的基础上对差异情况表得出结论，并按照我们 与日联科技公司签订的业务约定条款向日联科技公司报告我们的结论，除此之外 并无其他目的。我们不会就本报告的内容向任何其他方承担责任或义务。 我们根据《中国注册会计师其他鉴证业务准则第 3101 号一历史财务信息审 计或审阅以外的鉴证业务》的规定执行了鉴证工作。该准则要求我们遵守职业道 第 1 页 共 21 页 | 一、鉴证报告……………………………………………………………第 | 1—2 页 | | --- | --- | | 二、差异情况说明…………………………………………………………第 | 3 页 | | 三、差异情况表…………………………………………………………第 | 4-17 页 | | 四、附件………………………………………………………………第 | 18-21 页 | | (一)本所营业执照复印件………………………………………… | 第 ...

Core Insights - The company, through its wholly-owned subsidiary in Singapore, plans to acquire 66% of SSTI for approximately 26.895 million RMB, which will make SSTI a controlled subsidiary and included in the company's consolidated financial statements [1][2] Group 1: Acquisition Details - The acquisition amount is 4.89 million Singapore dollars, equivalent to about 26.895 million RMB, with the final transaction amount subject to exchange rate fluctuations at the time of delivery [1] - Post-acquisition, the company will hold a 66% stake in SSTI, which is a leading supplier of semiconductor testing, diagnostics, and failure analysis equipment [1] Group 2: Target Company Overview - SSTI has over 30 years of experience in the R&D of semiconductor testing and diagnostic equipment and possesses advanced design and manufacturing technologies [1] - The company has developed several industry-leading technologies and products, including Photon Emission Microscopy (PEM), Laser Time-of-Flight Probing (LTP), Scanning Optical Microscopy (SOM), and Thermal Microscopy (THM) [1] - SSTI's customer base includes many well-known domestic and international chip design, wafer manufacturing, and packaging testing companies, with nearly half of the top 20 global semiconductor manufacturers as clients [1] Group 3: Strategic Implications - This acquisition aligns with the company's strategy of horizontal expansion and vertical deepening, enhancing its business layout in the high-end semiconductor testing equipment sector [2] - The integration of technologies, products, and markets from both companies is expected to create synergies, complementing the existing semiconductor X-ray detection business [2] - The move is aimed at expanding the company's technical capabilities and business boundaries in the industrial testing field, supporting its vision of becoming a platform enterprise in industrial testing [2]

Core Viewpoint - The company, Ruitai Technology, announced the acquisition of a 66% stake in SSTI for approximately 2.69 billion RMB, aiming to expand its business in the high-end semiconductor testing equipment sector [1] Group 1: Acquisition Details - Ruitai Technology's wholly-owned subsidiary in Singapore plans to acquire SSTI for 4.89 million SGD, equivalent to about 2.69 billion RMB [1] - Upon completion of the transaction, Ruitai Technology will hold a 66% equity stake in SSTI, which will become a controlled subsidiary and included in the company's consolidated financial statements [1] Group 2: Target Company Overview - SSTI is one of the few companies globally that possesses advanced design and manufacturing technology for semiconductor testing, diagnostics, and failure analysis equipment [1] - The target company has developed multiple core technologies, including Photon Emission Microscopy (PEM), Laser Timing Probing (LTP), Scanning Optical Microscopy (SOM), and Thermal Microscopy (THM) [1] Group 3: Strategic Implications - This acquisition allows Ruitai Technology to further enhance its business layout in the high-end semiconductor testing equipment field [1]

Financial Performance - The company's operating revenue for the third quarter reached ¥276,694,202.06, representing a year-on-year increase of 54.57%[4] - The total profit for the quarter was ¥46,426,196.95, reflecting a growth of 43.55% compared to the same period last year[4] - The net profit attributable to shareholders was ¥42,016,896.08, which is an increase of 48.84% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥36,227,913.40, showing a significant increase of 126.09%[4] - Total operating revenue for the first three quarters of 2025 reached ¥737,085,605.14, a significant increase of 44% compared to ¥511,821,080.91 in the same period of 2024[21] - Net profit for the first three quarters of 2025 was ¥123,891,565.83, representing a 17.9% increase from ¥105,031,802.93 in the same period of 2024[22] - The company reported a total comprehensive income of ¥124,942,586.95 for the first three quarters of 2025, compared to ¥107,779,045.92 in the same period of 2024[22] Expenses and Investments - Research and development expenses totaled ¥31,799,170.34 for the quarter, accounting for 11.49% of operating revenue, which is an increase of 1 percentage point[5] - The company plans to continue increasing investment in AI algorithms and imaging software, as well as in new series and high-end X-ray detection equipment[10] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,997,132,162.58, marking a 9.84% increase from the end of the previous year[5] - The company's total current liabilities increased to RMB 554,666,306.42 from RMB 384,119,322.04, which is an increase of approximately 44.4%[18] - The company's total liabilities amounted to ¥641,175,825.97, an increase from ¥408,796,765.07 in the previous year[19] - Total equity attributable to shareholders reached ¥3,311,884,974.07, compared to ¥3,230,328,667.49 in the same period of 2024[19] Cash Flow - The company reported a net cash flow from operating activities of ¥39,415,533.60 for the quarter[4] - Cash flow from operating activities for the first three quarters of 2025 was ¥90,538,128.16, a recovery from a negative cash flow of -¥12,523,326.81 in the same period of 2024[25] - Cash inflow from financing activities amounted to $124,216,690.74, significantly higher than $5,881,588.35 in the previous period[26] - The net increase in cash and cash equivalents was $50,456,413.17, contrasting with a decrease of $273,658,153.71 in the previous period[26] Shareholder Information - The company has a total of 10 major shareholders, with the largest being Shanghai Linxin Investment Management Co., holding 4,907,025 shares[14] - The company has no significant changes in the shareholding structure or participation in margin trading activities during the reporting period[14] Market Strategy - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[16] Accounting Standards - The company will not apply new accounting standards starting from 2025[27]

证券代码：688531 证券简称：日联科技 公告编号：2025-064 日联科技集团股份有限公司 关于使用自有资金支付募投项目部分款项并以募集资 金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 日联科技集团股份有限公司（以下简称"公司"）于 2025 年 10 月 28 日召开 第四届董事会第十六次会议，审议通过了《关于使用自有资金支付募投项目部分 款项并以募集资金等额置换的议案》，同意公司及实施募集资金投资项目（以下 简称"募投项目"）的子公司在募投项目的实施期间，预先使用自有资金支付募 投项目部分款项，之后定期以募集资金等额置换，即从募集资金专户划转等额资 金至公司一般账户，该部分等额置换资金视同募投项目使用资金。保荐机构出具 了明确的核查意见。本次置换事项在董事会审批权限范围内，无需提交股东会审 议，现将具体情况公告如下： 一、募集资金的基本情况 经中国证券监督管理委员会于 2023 年 2 月 21 日出具的《关于同意无锡日联 科技股份有限公司首次公开发行股票注册的批复》（证监许可[2023]36 ...